81 |
|
The policy of public health genomics in Italy
|
for, t. G.; Simone, B.; Mazzucco, W.; Gualano, M. R.; Agodi, A.; Coviello, D.; Dagna Bricarelli, F.; Dallapiccola, B.; Di Maria, E.; Federici, A.
|
Elsevier ; Elsevier Science Pub. Co.
|
2013
|
|
|
82 |
|
The political economy of austerity and healthcare: Cross-national analysis of expenditure changes in 27 European nations 1995-2011
|
Reeves, A.; McKee, M.; Basu, S.; Stuckler, D.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
83 |
|
The political economy of the public-private mix in heath expenditure: An empirical review of thirteen OECD countries
|
Mou, H.
|
Elsevier : Elsevier Science Pub. Co.
|
2013
|
|
|
84 |
|
The primary-secondary care interface: Does provision of more services in primary care reduce referrals to medical specialists?
|
van Dijk, C. E.; Korevaar, J. C.; Koopmans, B.; de Jong, J. D.; de Bakker, D. H.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
85 |
|
The public disclosure of accreditation information in Australia: Stakeholder perceptions of opportunities and challenges
|
Greenfield, D.; Hinchcliff, R.; Pawsey, M.; Westbrook, J.; Braithwaite, J.
|
Elsevier : Elsevier Science Pub. Co.
|
2013
|
|
|
86 |
|
The public gets what the public wants: Experiences of public reporting in long-term care in Europe
|
Rodrigues, R.; Trigg, L.; Schmidt, A. E.; Leichsenring, K.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
87 |
|
The public health benefit of medicines: How it has been assessed in France? The principles and results of five years' experience
|
The, I. g.; Maison, P.; Zanetti, L.; Solesse, A.; Bouvenot, G.; Massol, J.
|
Elsevier : Elsevier Science Pub. Co.
|
2013
|
|
|
88 |
|
The Public Health Responsibility Deal: Brokering a deal for public health, but on whose terms?
|
Panjwani, C.; Caraher, M.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|